The News

Genomics in the news

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Read article

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Visit website

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Read article

Genomics features as one of Newsweek's most loved UK workplaces


4 Oct 2023

Genomics plc has made it into the Newsweek list of the UK's 100 Most Loved Workplaces 2023. The list is based on feedback from companies' employees and the rankings encompass a company's commitment to equality, diversity and inclusion, its dedication to employee growth and development and its ability to adapt to the needs of its workforce.

Visit website

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

Visit website

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Visit website

Our CEO Peter Donnelly speaks with John Pienaar at The Times Radio


22 Mar 2021

The NHS may soon be able to identify your risk of heart disease or a stroke well before it happens by studying your DNA.

Read article

Genomics in the news

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Genomics features as one of Newsweek's most loved UK workplaces


4 Oct 2023

Genomics plc has made it into the Newsweek list of the UK's 100 Most Loved Workplaces 2023. The list is based on feedback from companies' employees and the rankings encompass a company's commitment to equality, diversity and inclusion, its dedication to employee growth and development and its ability to adapt to the needs of its workforce.

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Sir Peter Donnelly gives Plenary Keynote at ELRIG Research & Innovation 2021


23 Mar 2021

Empowering Drug Discovery through Genomics

Our CEO Peter Donnelly speaks with John Pienaar at The Times Radio


22 Mar 2021

The NHS may soon be able to identify your risk of heart disease or a stroke well before it happens by studying your DNA.

Genomics in the news

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Genomics features as one of Newsweek's most loved UK workplaces


4 Oct 2023

Genomics plc has made it into the Newsweek list of the UK's 100 Most Loved Workplaces 2023. The list is based on feedback from companies' employees and the rankings encompass a company's commitment to equality, diversity and inclusion, its dedication to employee growth and development and its ability to adapt to the needs of its workforce.

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Sir Peter Donnelly gives Plenary Keynote at ELRIG Research & Innovation 2021


23 Mar 2021

Empowering Drug Discovery through Genomics

Our CEO Peter Donnelly speaks with John Pienaar at The Times Radio


22 Mar 2021

The NHS may soon be able to identify your risk of heart disease or a stroke well before it happens by studying your DNA.

Genomics in the news

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Read article

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Visit website

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Read article

Genomics features as one of Newsweek's most loved UK workplaces


4 Oct 2023

Genomics plc has made it into the Newsweek list of the UK's 100 Most Loved Workplaces 2023. The list is based on feedback from companies' employees and the rankings encompass a company's commitment to equality, diversity and inclusion, its dedication to employee growth and development and its ability to adapt to the needs of its workforce.

Visit website

NHS pilots genetic testing to predict risk of heart disease


17 Jan 2022

An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.

Visit website

NHS launches new polygenic scores trial for heart disease


29 Apr 2021

The NHS and UK biotech company Genomics plc have announced a pilot study that aims to more accurately predict patients’ risk of heart disease using a new integrated polygenic and clinical risk tool.

Visit website

Our CEO Peter Donnelly speaks with John Pienaar at The Times Radio


22 Mar 2021

The NHS may soon be able to identify your risk of heart disease or a stroke well before it happens by studying your DNA.

Read article